Registration Dossier
Registration Dossier
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 240-457-5 | CAS number: 16409-43-1
Endpoint summary
Administrative data
Description of key information
Skin sensitisation (Bühler equivalent to OECD TG 406): not skin sensitizing (RIFM 1993)
Key value for chemical safety assessment
Skin sensitisation
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (not sensitising)
- Additional information:
In the chosen key study, a Buehler test equivalent to OECD guideline 406 was conducted with male and female Hartley guinea pigs. For induction, a 0.3 ml aliquot of 50% rose oxide in diethyl phthalate (DEP) was placed under occlusion to the clipped left shoulder for 6 hours. This procedure was repeated at the same site, once a week for the next 2 weeks, until a total of 3 exposures were applied. After a 2-week rest period, 0.5, 1.5, and 5% test substance in DEP were applied to previously untreated sites for 6 hours under occlusion. No skin sensitization was observed for rose oxide under the chosen testing conditions (RIFM 1993).
Three studies with human volunteers from secondary sources with limited information are available. In an RIPT, 9 dermal applications for induction and 1 challenge application of 1.25 % rose oxide in ethanol resulted in 0/40 sensitization reactions (IFF 1964). Ten dermal induction applications followed by a single dermal challenge application of 5% rose oxide in dimthylphtalate resulted in dermal reactions in 5/51 volunteers (Givaudan 1965). The relevance of the observed skin reactions for skin sensitization cannot be assessed. In a human maximization test, application of 2% rose oxide in petrolatum did not result in skin sensitization reactions in 25 volunteers (Kligman 1978).
Overall, based on the key study (Bühler test in guinea pigs) and the majority of scarcly reported human test data, rose oxide is found to show no skin sensitization potential.
Respiratory sensitisation
Endpoint conclusion
- Additional information:
no data available
Justification for classification or non-classification
The present data on dermal sensitization do not fulfill the criteria laid down in 67/548/EEC and CLP, and therefore, a non-classification is warranted.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
